Evidence map›Paper›PMID 26161560›Full record

ArticlePloS one2015

Quantitative Analysis of MicroRNAs in Vaccinia virus Infection Reveals Diversity in Their Susceptibility to Modification and Suppression.

Amy H Buck, Alasdair Ivens, Katrina Gordon, Nicola Craig, Alexandre Houzelle, Alice Roche, Neil Turnbull, Philippa M Beard

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Translational control during poxvirus infection.Wiley interdisciplinary reviews. RNA · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Amy H BuckCentre for Immunity, Infection and Evolution, University of Edinburgh, King's Buildings, Edinburgh, United Kingdom.
Alasdair IvensCentre for Immunity, Infection and Evolution, University of Edinburgh, King's Buildings, Edinburgh, United Kingdom.
Katrina GordonCentre for Immunity, Infection and Evolution, University of Edinburgh, King's Buildings, Edinburgh, United Kingdom.
Nicola CraigInfection and Immunity, The Roslin Institute / Royal (Dick) School of Veterinary Studies, Easter Bush, Midlothian, United Kingdom.
Alexandre HouzelleInfection and Immunity, The Roslin Institute / Royal (Dick) School of Veterinary Studies, Easter Bush, Midlothian, United Kingdom.
Alice RocheInfection and Immunity, The Roslin Institute / Royal (Dick) School of Veterinary Studies, Easter Bush, Midlothian, United Kingdom.
Neil TurnbullInfection and Immunity, The Roslin Institute / Royal (Dick) School of Veterinary Studies, Easter Bush, Midlothian, United Kingdom.
Philippa M BeardInfection and Immunity, The Roslin Institute / Royal (Dick) School of Veterinary Studies, Easter Bush, Midlothian, United Kingdom.
Roslin Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J001279/1Medical Research Council G0900740Medical Research Council MR/K001744/1Wellcome Trust 095831Wellcome Trust 095831MAWellcome Trust WT097394AIA
6 · The paper itself

Abstract

Vaccinia virus (VACV) is a large cytoplasmic DNA virus that causes dramatic alterations to many cellular pathways including microRNA biogenesis. The virus encodes a poly(A) polymerase which was previously shown to add poly(A) tails to the 3' end of cellular miRNAs, resulting in their degradation by 24 hours post infection (hpi). Here we used small RNA sequencing to quantify the impact of VACV infection on cellular miRNAs in human cells at both early (6 h) and late (24 h) times post infection. A detailed quantitative analysis of individual miRNAs revealed marked diversity in the extent of their modification and relative change in abundance during infection. Some miRNAs became highly modified (e.g. miR-29a-3p, miR-27b-3p) whereas others appeared resistant (e.g. miR-16-5p). Furthermore, miRNAs that were highly tailed at 6 hpi were not necessarily among the most reduced at 24 hpi. These results suggest that intrinsic features of human cellular miRNAs cause them to be differentially polyadenylated and altered in abundance during VACV infection. We also demonstrate that intermediate and late VACV gene expression are required for optimal repression of some miRNAs including miR-27-3p. Overall this work reveals complex and varied consequences of VACV infection on host miRNAs and identifies miRNAs which are largely resistant to VACV-induced polyadenylation and are therefore present at functional levels during the initial stages of infection and replication.

Indexed as

AnimalsBase SequenceBlotting, NorthernCHO CellsCricetinaeCricetulusGene Expression ProfilingGenetic Predisposition to DiseaseGenetic VariationHeLa CellsHumansMicroRNAsSequence Analysis, RNAVacciniaVaccinia virusMicroRNAs

Identifiers

PMID26161560
PMCPMC4498801
OpenAlexW1826049490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.